Biotech
AmplifyBio
AmplifyBio raises $50M Growth at $280M valuation
$50M
Total Raised
Growth
Latest Round
2020
Founded
400+
Employees
New Albany, OH
1 min read
Quick Facts
Valuation
$280M
Latest Round Size
$50M
Latest Round Date
November 2024
AmplifyBio: Growth Funding Round
AmplifyBio has successfully raised $50M in Growth funding, reaching a valuation of $280M.
Company Overview
Drug development company providing preclinical and clinical services
Funding Details
The Growth round was led by Vitrian, with participation from Safar Partners.
Company Information
- Headquarters: New Albany, OH
- Founded: 2020
- Employees: 400+
- Category: Biotech
Investment
AmplifyBio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Vitrian: Verified investor in Growth
- Safar Partners: Verified investor in Growth
Key Investors
Vitrian
Lead Investor
Verified investor in Growth
Safar Partners
Investor
Verified investor in Growth
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M